Home » CIPLA TIES UP WITH IVAX FOR US MARKET
CIPLA TIES UP WITH IVAX FOR US MARKET
Cipla has teamed up with generic major Ivax, now Teva, to supply an active pharmaceutical ingredient (API) for a paediatric drug in US market. Following the expiry of the patent on this drug in September last year, Teva bagged the exclusive marketing rights. India Business (http://timesofindia.indiatimes.com/articleshow/1890873.cms)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct